Mutation markers: Improved diagnostics for neuropathologies
Explore the value of mutation markers for improved cancer diagnosis, classification, and prediction of prognosis.
Source: selectscience.net
Page 3 - Cell Marque News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Cell Marque. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Cell Marque Today - Breaking & Trending Today
Cureus | Expression of c-Myc, Bcl2, Bcl6, and Cyclin D1 in High-Grade B-Cell Lymphoma
Background High-grade B-cell lymphomas (HGBLs), with c-Myc, Bcl2, and/or Bcl6 rearrangement, are aggressive neoplasms with poor clinical outcomes. Cyclin D1 is a proto-oncogene that is generally expressed by mantle cell lymphoma, its variants, and many other neoplasms. Aim The aim of this study is to investigate the expression and frequency of cyclin D1 in HGBL and its association with double expressor and triple expressor lymphomas. A few pieces of research have been reported on the expression of cyclin D1 in triple-hit lymphoma, renaming it quadruple-hit lymphoma. In the present study, we a...
Source: cureus.com
Postmortem Assessment of Olfactory Tissue Degeneration and Microvasculopathy in Patients With COVID-19
This cohort study evaluates the association of COVID-19 infection with olfactory bulb by performing an ultrastructural and histopathological analysis of patient
Source: jamanetwork.com
-p120-(red)-on-lobular-breast-carcinoma-Home.jpg)
Breast cancer subtypes in an era of personalized medicine
Discover how immunohistochemistry is supporting the identification of molecular subtypes of breast cancer
Source: selectscience.net
Breast cancer subtypes in an era of personalized medicine
Discover how immunohistochemistry is supporting the identification of molecular subtypes of breast cancer
Source: selectscience.net